Updates on the management of non-melanoma skin cancer (NMSC)

A Fahradyan, AC Howell, EM Wolfswinkel, M Tsuha… - Healthcare, 2017 - mdpi.com
Non-melanoma skin cancers (NMSCs) are the most common malignancy worldwide, of
which 99% are basal cell carcinomas (BCCs) and squamous cell carcinomas (SCCs) of …

Photodynamic therapy for basal cell carcinoma: the clinical context for future research priorities

NJ Collier, LE Rhodes - Molecules, 2020 - mdpi.com
Photodynamic therapy (PDT) is an established treatment option for low-risk basal cell
carcinoma (BCC). BCC is the most common human cancer and also a convenient cancer in …

[HTML][HTML] Metformin overcomes metabolic reprogramming-induced resistance of skin squamous cell carcinoma to photodynamic therapy

M Mascaraque-Checa, M Gallego-Rentero… - Molecular …, 2022 - Elsevier
Objective Cancer metabolic reprogramming promotes resistance to therapies. In this study,
we addressed the role of the Warburg effect in the resistance to photodynamic therapy (PDT) …

Combination vismodegib and photodynamic therapy for multiple basal cell carcinomas

JM Rizzo, RJ Segal, NC Zeitouni - Photodiagnosis and photodynamic …, 2018 - Elsevier
Background Oral vismodegib therapy and photodynamic therapy (PDT) are non-invasive
treatments for basal cell carcinoma (BCC) with overlapping utility in widespread BCCs and …

Skin cancer therapeutics: Nano-drug delivery vectors—present and beyond

M Lalan, P Shah, K Barve, K Parekh, T Mehta… - Future Journal of …, 2021 - Springer
Background Skin cancers are among the widely prevalent forms of cancer worldwide. The
increasing industrialization and accompanied environmental changes have further …

Characterisation of resistance mechanisms developed by basal cell carcinoma cells in response to repeated cycles of Photodynamic Therapy

SR Lucena, A Zamarrón, E Carrasco, MA Marigil… - Scientific reports, 2019 - nature.com
Photodynamic Therapy (PDT) with methyl-aminolevulinate acid (MAL-PDT) is being used for
the treatment of Basal cell carcinoma (BCC), but recurrences have been reported. In this …

Biomarkers of basal cell carcinoma resistance to methyl-aminolevulinate photodynamic therapy

T Gracia-Cazana, M Mascaraque, SR Lucena… - PloS one, 2019 - journals.plos.org
Background Methyl-aminolevulinate photodynamic therapy (MAL-PDT) is an excellent
option for the treatment of basal cell carcinoma (BCC). However, up to 25% of cases are …

A comprehensively revised strategy that improves the specific activity and long-term stability of clinically relevant 89 Zr-immuno-PET agents

NB Bhatt, DN Pandya, S Rideout-Danner… - Dalton …, 2018 - pubs.rsc.org
Zirconium-89 is currently being used in numerous clinical trials involving monoclonal
antibodies and positron emission tomography. This report describes a revised strategy that …

Clinical, histological and immunohistochemical markers of resistance to methyl aminolaevulinate photodynamic therapy in Bowen disease

T Gracia‐Cazaña, N Salazar… - British Journal of …, 2018 - academic.oup.com
DEAR EDITOR, Bowen disease (BD) is an intraepidermal squamous cell carcinoma (SCC),
which appears principally on photoexposed areas. 1 Methyl aminolaevulinate (MAL) …

Reduced graphene oxide, but not carbon nanotubes, slows murine melanoma after thermal ablation using LED light in B16F10 lineage cells

RFO de Paula, IA Rosa, IFM Gafanhão, JL Fachi… - … , Biology and Medicine, 2020 - Elsevier
Photodynamic therapy is a minimally invasive health technology used to treat cancer and
other non-malignant diseases, as well as inactivation of viruses, bacteria and fungi. In this …